Your browser doesn't support javascript.
Estimating infectiousness throughout SARS-CoV-2 infection course.
Jones, Terry C; Biele, Guido; Mühlemann, Barbara; Veith, Talitha; Schneider, Julia; Beheim-Schwarzbach, Jörn; Bleicker, Tobias; Tesch, Julia; Schmidt, Marie Luisa; Sander, Leif Erik; Kurth, Florian; Menzel, Peter; Schwarzer, Rolf; Zuchowski, Marta; Hofmann, Jörg; Krumbholz, Andi; Stein, Angela; Edelmann, Anke; Corman, Victor Max; Drosten, Christian.
  • Jones TC; Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
  • Biele G; German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.
  • Mühlemann B; Centre for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, U.K.
  • Veith T; Norwegian Institute of Public Health, 0473 Oslo, Norway.
  • Schneider J; University of Oslo, 0315 Oslo, Norway.
  • Beheim-Schwarzbach J; Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
  • Bleicker T; German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.
  • Tesch J; Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
  • Schmidt ML; German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.
  • Sander LE; Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
  • Kurth F; German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.
  • Menzel P; Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
  • Schwarzer R; Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
  • Zuchowski M; Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
  • Hofmann J; Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
  • Krumbholz A; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
  • Stein A; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
  • Edelmann A; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Medicine I, University Medical Centre Hamburg-Eppendorf, 20359 Hamburg, Germany.
  • Corman VM; Labor Berlin-Charité Vivantes GmbH, Sylter Straße 2, 13353 Berlin, Germany.
  • Drosten C; Labor Berlin-Charité Vivantes GmbH, Sylter Straße 2, 13353 Berlin, Germany.
Science ; 373(6551)2021 07 09.
Article in English | MEDLINE | ID: covidwho-1243685
ABSTRACT
Two elementary parameters for quantifying viral infection and shedding are viral load and whether samples yield a replicating virus isolate in cell culture. We examined 25,381 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Germany, including 6110 from test centers attended by presymptomatic, asymptomatic, and mildly symptomatic (PAMS) subjects, 9519 who were hospitalized, and 1533 B.1.1.7 lineage infections. The viral load of the youngest subjects was lower than that of the older subjects by 0.5 (or fewer) log10 units, and they displayed an estimated ~78% of the peak cell culture replication probability; in part this was due to smaller swab sizes and unlikely to be clinically relevant. Viral loads above 109 copies per swab were found in 8% of subjects, one-third of whom were PAMS, with a mean age of 37.6 years. We estimate 4.3 days from onset of shedding to peak viral load (108.1 RNA copies per swab) and peak cell culture isolation probability (0.75). B.1.1.7 subjects had mean log10 viral load 1.05 higher than that of non-B.1.1.7 subjects, and the estimated cell culture replication probability of B.1.1.7 subjects was higher by a factor of 2.6.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asymptomatic Infections / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Europa Language: English Year: 2021 Document Type: Article Affiliation country: Science.abi5273

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Asymptomatic Infections / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Europa Language: English Year: 2021 Document Type: Article Affiliation country: Science.abi5273